Abstract
It has been suggested that patients in whom atrial fibrillation (AF) is associated with poor exercise tolerance respond better to treatment with xamoterol plus digoxin than to digoxin alone; this may be attributable to better control of exercise induced tachycardia. We have examined data obtained during studies comparing digoxin and two calcium antagonists in the treatment of AF to see whether subgroups of patients with particularly poor exercise tolerance, rheumatic heart disease or rapid post-exercise heart rates might derive particular benefit from one modality of treatment as opposed to another. The results do not indicate that calcium antagonists improve exercise tolerance compared with digoxin in any of these subgroups despite achieving consistently better control of exercise induced tachycardia.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Lang R., Klein H. O., Weiss E., David D., Sareli P., Levy A., Guerrero J., Di Segni E., Kaplinsky E. Superiority of oral verapamil therapy to digoxin in treatment of chronic atrial fibrillation. Chest. 1983 Mar;83(3):491–499. doi: 10.1378/chest.83.3.491. [DOI] [PubMed] [Google Scholar]
- Lewis R., Lakhani M., Moreland T. A., McDevitt D. G. A comparison of verapamil and digoxin in the treatment of atrial fibrillation. Eur Heart J. 1987 Feb;8(2):148–153. doi: 10.1093/oxfordjournals.eurheartj.a062242. [DOI] [PubMed] [Google Scholar]
- Molajo A. O., Coupe M. O., Bennett D. H. Effect of Corwin (ICI 118587) on resting and exercise heart rate and exercise tolerance in digitalised patients with chronic atrial fibrillation. Br Heart J. 1984 Oct;52(4):392–395. doi: 10.1136/hrt.52.4.392. [DOI] [PMC free article] [PubMed] [Google Scholar]